South Korean medical device maker Osteonic has agreed to buy 51% of FoxEyes, a privately held spine surgery robot developer in Texas, for KRW 3 billion, according to an SK Securities report cited by iRobotNews. Osteonic announced the deal on 4 November.
FoxEyes, founded in 2024, is preparing to bring its F1 VSR spine surgery robot, which uses vision camera tracking, to market. Osteonic plans to sell its spinal implants to hospitals that buy the robot, and later to move into robots for fracture and cosmetic surgery.
